SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001571049-17-001338
Filing Date
2017-02-14
Accepted
2017-02-14 13:12:23
Documents
1
Group Members
HENRY A. PLAIN, JR.JEAN M. GEORGELIGHTSTONE VENTURES (A), L.P.LSV ASSOCIATES, LLCMICHAEL A. CARUSI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G t1700105_sc13g.htm SC 13G 130221
  Complete submission text file 0001571049-17-001338.txt   131903
Mailing Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B14301 CAMBRIDGE MA 02139 (617) 401-4060
Ra Pharmaceuticals, Inc. (Subject) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89680 | Film No.: 17606263
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116
Business Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116 (617) 933-3770
Lightstone Ventures, L.P. (Filed by) CIK: 0001572522 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G